{"originalText": "，于2014年？月予以直肠癌手术，，术后病理：直肠肿物（活检，2014-01-24），：- 浸润性中分化腺癌。2. 直肠距肛门5厘米（活检，2014-01-24），：- 管状腺瘤。术后予以？周期化疗。2016年10月因肺肿物，予以（左肺上叶），切除：术后病理- 肺腺癌，以实性生长方式为主，送检肿物最大径2.1CM；- 癌累及脏层胸膜；- 可见脉管癌栓；- 淋巴结未见癌转移（第10组0/5、第11组0/2、第7组0/1、4R 0/2、2R 0/2、第8组0/3、第12组0/1）；- ，肿瘤病理分期：PT2AN0。，免疫组化结果显示: ALK-VENTANA(－),CDX2(－),CK20(－),CK7(+),NAPSIN A(－),SATB-2(－),TTF-1(+)，免疫组化表型支持肺原发腺癌。术后予以？周期化疗。于2017-1月10日复查发现术后复发，CT，显示：，胸部增强：左肺上叶术后，支气管断端处见结节状灶，范围约15X14MM（IMA31），左肺门新见肿大淋巴结，约30X16MM（IMA27），不能除外肿瘤复发伴淋巴结转移，需进一步检查明确。左肺下叶后段新见小片状灶，中央见空洞，大小约18X15MM（IMA24），边缘模糊不清，其性质待定，建议抗炎后短期复查。右肺未见新发结节。纵隔、右肺门、锁骨下区及两腋上未见肿大淋巴结。左侧胸膜多处局限增厚同前相仿。左侧见少量胸腔积液。右侧未见胸水征象。于2017-1-25日因浅表淋巴结无肿大（1），左肺上叶原发腺癌术后：PT2AN0M0，左肺门淋巴结转移；（2）直肠浸润性中分化腺癌术后，已测EGFR突变阴性，KRAS突变，予以奈达铂75MG/M*2(分为2天用,70MG/D1,60MG/D2)+培美曲塞500MG/M*2 800MG+恩度15患者近4日出现便秘，口服乳果糖，番泻叶及甘油灌肠剂治疗效果不佳，无明显腹胀，有排气。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 11, "end_pos": 14}, {"end_pos": 25, "label_type": "解剖部位", "overlap": 0, "start_pos": 23}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 46, "end_pos": 54}, {"end_pos": 60, "label_type": "解剖部位", "overlap": 0, "start_pos": 58}, {"end_pos": 63, "label_type": "解剖部位", "overlap": 0, "start_pos": 61}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 85, "end_pos": 89}, {"end_pos": 110, "label_type": "解剖部位", "overlap": 0, "start_pos": 109}, {"end_pos": 120, "label_type": "解剖部位", "overlap": 0, "start_pos": 116}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 131, "end_pos": 134}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 346, "end_pos": 351}, {"label_type": "影像检查", "overlap": 0, "start_pos": 382, "end_pos": 384}, {"end_pos": 391, "label_type": "解剖部位", "overlap": 0, "start_pos": 389}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 394, "end_pos": 400}, {"end_pos": 404, "label_type": "解剖部位", "overlap": 0, "start_pos": 401}, {"end_pos": 434, "label_type": "解剖部位", "overlap": 0, "start_pos": 431}, {"end_pos": 441, "label_type": "解剖部位", "overlap": 0, "start_pos": 438}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 462, "end_pos": 472}, {"end_pos": 488, "label_type": "解剖部位", "overlap": 0, "start_pos": 482}, {"end_pos": 544, "label_type": "解剖部位", "overlap": 0, "start_pos": 542}, {"end_pos": 553, "label_type": "解剖部位", "overlap": 0, "start_pos": 551}, {"end_pos": 557, "label_type": "解剖部位", "overlap": 0, "start_pos": 554}, {"end_pos": 562, "label_type": "解剖部位", "overlap": 0, "start_pos": 558}, {"end_pos": 566, "label_type": "解剖部位", "overlap": 0, "start_pos": 563}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 594, "end_pos": 598}, {"end_pos": 604, "label_type": "解剖部位", "overlap": 0, "start_pos": 603}, {"end_pos": 625, "label_type": "解剖部位", "overlap": 0, "start_pos": 620}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 632, "end_pos": 642}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 652, "end_pos": 660}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 664, "end_pos": 676}, {"end_pos": 700, "label_type": "药物", "overlap": 0, "start_pos": 697}, {"end_pos": 736, "label_type": "药物", "overlap": 0, "start_pos": 732}, {"end_pos": 754, "label_type": "药物", "overlap": 0, "start_pos": 752}, {"end_pos": 771, "label_type": "药物", "overlap": 0, "start_pos": 768}, {"end_pos": 775, "label_type": "药物", "overlap": 0, "start_pos": 772}, {"end_pos": 781, "label_type": "药物", "overlap": 0, "start_pos": 776}, {"end_pos": 792, "label_type": "解剖部位", "overlap": 0, "start_pos": 791}]}
